IIP Advisory

Value Quantified. Risk Optimised. IP Monetised.

Our IP Advisory group brings patent attorneys, IP lawyers, IP valuers, IP insurance and IP commercialisation advisers together under one roof.

This rare breadth of expertise lets us see the whole picture: the value, the risk and the commercial potential of your intangible assets.

Intangible assets are everywhere.

Most of your value is intangible.

Technology, data, brands, know-how and customer relationships increasingly underpin competitive advantage and enterprise value. Businesses that understand and actively manage these assets can attract investment, negotiate better transactions and capture new sources of growth.

Conceptual illustration. Actual value depends on the asset and its commercial prospects. © IIP Group Pty Ltd.

Our Services

With three integrated service lines, we help you understand the value of your IP, cut the risk of holding it, and help you earn money from it.


Value Quantified

Understand the strength, value and economics of your IP, with evidence to support decisions, transactions and negotiations.


Risk Optimised

Understand and optimise the risks that influence IP value. We combine IP audits, insurance and strategic advice to reduce exposure, strengthen commercial positioning and enhance portfolio value.


IP Monetisation & Dealmaking

Turn IP into income. We help you license it, sell it and negotiate better terms, from strategy to signed deal.

Value Quantified

IP Valuation

Specialist valuations for strategic, transaction and compliance purposes.

How we help

Our specialists value technology, data, brands and businesses that depend on intangible assets. Every valuation considers the functional, legal and financial characteristics of the IP asset and, where applicable, is prepared in accordance with recognised local and international valuation standards and guidelines.

IP Valuation services

Case Studies

Featured

Cross-border IP valuation for tax purposes

The valuation provided a defensible allocation of value across the acquired IP for tax purposes, reflecting the economic contribution of the assets rather than the size or apparent prominence of the portfolio.

Value Quantified

IP Licensing & Royalty Opinions

Practical royalty and licensing advice built on market evidence and IP economics.

How we help

We provide independent royalty opinions and practical licensing advice for transactions, negotiations, and disputes.

IP Licensing & Royalty Opinion services

Case Studies

Featured

Licensing and royalty advice for subsea technology

The work helped frame the royalty within the wider economics of the deal and identify terms that protected the client’s ongoing use of the technology while supporting commercialisation and a potential new licensing revenue stream.

Value Quantified

Snapshot Score™

A fast, fixed-fee rating of how commercially attractive a technology is, reviewed by our patent attorneys and valuers.

What is it?

The IIP Snapshot Score™ is a fixed-fee assessment of a technology or patent portfolio, scored on a five-point scale. It answers three questions: Does the technology do something better? How long could that advantage last? Is there a market worth pursuing?

Snapshot Score™ inputs

Prices start from $2,500 (plus GST). The Snapshot Score™ can be used on its own or as an input into a valuation, royalty opinion or transaction.

Snapshot Score™: example findings at a glance

Where it helps

Case Studies

Featured

Valuing a clinical-stage biotech asset to support exit planning

The analysis clarified the relationship between current IP value and the company’s market capitalisation, and quantified upside and downside scenarios to support board discussions and exit strategy planning.

Risk Optimised

IP Audit & Risk Assessments

Understand and optimise the risks that influence IP value. We combine IP audits, insurance and strategic advice to reduce exposure, strengthen commercial positioning and enhance portfolio value.

How we help

IP risk extends well beyond patents and trademarks. Critical value can sit in software, data, trade secrets, know-how, copyright, contracts and internal processes, often without the same visibility or protection as registered rights.

We take a business-wide view of IP to identify what is important, how it is protected and where material gaps or exposures exist. This can include IP ownership and chain of title, technology and portfolio mapping, contractual protections, freedom-to-operate and competitive risks, information controls, governance and insurance.

We then assess the commercial significance of the findings and develop practical priorities for strengthening protection, managing risk and directing future IP investment.

IP Audit & Risk Assessment services

Case Studies

Featured

Finding the next layer of value in an established technology business

Management could see where value depended on registered rights and where it depended on less visible assets. The resulting roadmap connected future IP decisions with products, recurring revenue and potential licensing opportunities, rather than treating each patent as an isolated investment.

Risk Optimised

IP Insurance

Use IP insurance to protect your IP, reduce risk and optimise value.

How we help

IP disputes can be expensive and difficult to fund, particularly where a company’s value depends heavily on a small number of patents, technologies or brands. IP insurance can provide financial protection against these risks and give businesses greater confidence to invest, transact and commercialise.

We combine IP, valuation and insurance expertise to assess the assets and exposures, determine appropriate cover and help position the risk for brokers and underwriters. We work with Australian and international insurance markets to structure cover around the IP, the risks it faces and the commercial objectives of the business.

IP Insurance services

Case Studies

Featured

IP insurance: reducing risk and strengthening value

Assessing IP value, risk and insurance together provides a stronger basis for deciding what to insure and how much cover is appropriate. For many technology businesses, intellectual property underpins a significant share of enterprise value.

Risk Optimised

Portfolio Pruning

Drop patents that cost more than they earn.

How we help

Strategic optimisation of your IP portfolio: keep the high-value assets, drop the patents that cost more than they earn, and redirect the budget to the IP that matters. Pruning decisions draw on the same assessment tools we use for valuation and risk, so what stays and what goes is decided on evidence.

Case Studies

Featured

Finding licensing opportunities beyond a manufacturer’s core products

The programme identified a structured path for pursuing licensing opportunities outside the company’s core business. It helped management focus its efforts on selected assets, markets and counterparties while retaining the rights needed for existing products.

IP Monetisation & Dealmaking

IP Licensing & Divestment

License or sell the IP you are not using.

How we help

Structured pathways to earn from the IP you are not using: identifying monetisation opportunities in non-core or under-used assets, then running the licensing or sale campaign to a signed deal.

IP Licensing & Divestment services

Case Studies

Featured

Taking a building-products invention from protection to sale

The relevant patent rights were subsequently acquired by an international industry participant, and illustrates how protection, product communication and commercial preparation can support the same objective: making an invention understandable, assessable and transferable to a business positioned to take it further.

IP Monetisation & Dealmaking

Licensing Strategy & Commercial Terms

Licence models, prices and terms that hold up.

How we help

We design the licensing structure, upfront fees, milestones and royalty mechanisms, and back the numbers with royalty benchmarking so the terms survive negotiation and enforcement.

Licensing Strategy & Commercial Terms services

Case Studies

Featured

Assessing the royalty on a manufactured safety product

The client had an independent basis for assessing the proposed royalty and negotiating the broader licence. Our advice helped shape a structure that considered the rate alongside the other commercial terms and the potential scale of a global licence.

IP Monetisation & Dealmaking

Buy-side & Sell-side IP Advisory

Licence models, prices and terms that hold up.

How we help

Sell-side, we evidence the technology’s contribution to value and strengthen your negotiating position. Buy-side, we discipline bidding by identifying the key sources of upside and downside risk before you commit.

Case Studies

Featured

Allocating shared IP in a corporate separation

The analysis provided a basis for allocating ownership and licensing rights in the proposed separation. It helped management consider the commercial viability of each business alongside the asset split, without assuming that the restructuring had already completed.

IP Monetisation & Dealmaking

Diligence-ready Materials

IP packs that survive a buyer’s scrutiny.

How we help

Investor, buyer and partner-ready IP packs that survive scrutiny: what the assets are, who owns them, how strong the protection is and what they earn. Good materials speed up deal timelines and stop diligence questions becoming price reductions.

Case Studies

Featured

Early-stage medtech valuation using a VC scorecard

The analysis gave the company an evidence-based view of its position relative to comparable early-stage businesses, supporting more informed valuation discussions with prospective investors.

IP Monetisation & Dealmaking

Negotiation Support & Term Optimisation

Numbers and arguments for the negotiating table.

How we help

We provide deal-specific valuation analysis, royalty benchmarking and commercial framing, and identify what the other side is likely to challenge so you get ahead of it.

Case Studies

Featured

Licensing advice to support monetisation of a healthcare data asset

Our advice gave the organisation an independent basis for negotiations and helped it determine how to participate in the value created from an asset that had been built progressively over many years.

IP Monetisation & Dealmaking

Competitive Intelligence

What competitors are patenting, and where you are free to operate.

How we help

Strategic insight into technology trends, market developments and competitor activity: what rivals are patenting, where you are free to operate, and what threats are forming. We use it to guide licensing, filing and market strategy, and to strengthen litigation and negotiation positions.

Case Studies

Featured

Finding a defensible position in a crowded marine-technology market

The completed landscape and workshop gave the client a more clearly defined concept and a structured basis for the next development decisions. Its value to date lies in clarifying differentiation and priorities before further expenditure, not in a claimed product launch or investment outcome.

Advisory Leadership

For our broader team, visit Our People.

Matthew Yeates

Principal (MD) | IP Advisory

Specialises in IP strategy, licensing and monetisation, and is a board member. Named to the IAM Strategy 300 every year from 2021 to 2026, and an IAM Strategy 300 Global Leader for 2026.

Claire Ramsay

Principal | Integrated IP Law

Specialist IP lawyer in commercial IP transactions, licensing, IP risk and disputes. Formerly Legal Counsel (IP) at Rio Tinto and Associate to Justice Susan Crennan in the Federal Court and High Court of Australia.

Rob Burnside

Director | IP Advisory

Specialist in valuing IP and intangible assets across M&A, tax, capital raising, financial reporting, licensing and IP strategy. Formerly a Director at Deloitte, where he helped establish its Australian IP value advisory practice.

Juan Paul Rebola (JP)

Special Counsel | IP Advisory

Over 15 years of strategic and commercial experience across Australia and Southeast Asia, including as General Manager, Transformation at Telstra. Specialises in AI transformation, growth strategy and IP monetisation.

Who we serve

Select your organisation type. We’ve structured our FAQs around the questions each client persona actually asks us.

Organisation type

Law firms

Assessing commercially important IP in a cross-border acquisition

A US-domiciled multinational mining company was negotiating a joint venture with a small-cap Australian miner to develop a new metals processing technology.

View case study →

Corporates & SMEs

Allocating shared IP in a corporate separation

A US-domiciled multinational mining company was negotiating a joint venture with a small-cap Australian miner to develop a new metals processing technology.

View case study →

Corporates & SMEs

Finding licensing opportunities beyond a manufacturer’s core products

A US-domiciled multinational mining company was negotiating a joint venture with a small-cap Australian miner to develop a new metals processing technology.

View case study →

Corporates & SMEs

IP insurance: reducing risk and strengthening value

A US-domiciled multinational mining company was negotiating a joint venture with a small-cap Australian miner to develop a new metals processing technology.

View case study →

VC & Private equity

Strengthening a software company’s IP position ahead of exit

A US-domiciled multinational mining company was negotiating a joint venture with a small-cap Australian miner to develop a new metals processing technology.

View case study →

Startups

Finding a defensible position in a crowded marine-technology market

A US-domiciled multinational mining company was negotiating a joint venture with a small-cap Australian miner to develop a new metals processing technology.

View case study →

Corporates & SMEs

Finding the next layer of value in an established technology business

A US-domiciled multinational mining company was negotiating a joint venture with a small-cap Australian miner to develop a new metals processing technology.

View case study →

Research institutions & TTOs

Invention disclosure assessment

A US-domiciled multinational mining company was negotiating a joint venture with a small-cap Australian miner to develop a new metals processing technology.

View case study →

Corporates & SMEs

Licensing and royalty advice for subsea technology

A US-domiciled multinational mining company was negotiating a joint venture with a small-cap Australian miner to develop a new metals processing technology.

View case study →

Research institutions & TTOs

Setting commercial terms for university spin-out IP

A US-domiciled multinational mining company was negotiating a joint venture with a small-cap Australian miner to develop a new metals processing technology.

View case study →

Corporates & SMEs

Assessing the royalty on a manufactured safety product

A US-domiciled multinational mining company was negotiating a joint venture with a small-cap Australian miner to develop a new metals processing technology.

View case study →

Corporates & SMEs

Licensing advice to support monetisation of a healthcare data asset

A US-domiciled multinational mining company was negotiating a joint venture with a small-cap Australian miner to develop a new metals processing technology.

View case study →

Boards & accounting firms

Valuing early-stage software to support carve out and recapitalisation of business

A US-domiciled multinational mining company was negotiating a joint venture with a small-cap Australian miner to develop a new metals processing technology.

View case study →

Corporates & SMEs

Cross-border IP valuation for tax purposes

A US-domiciled multinational mining company was negotiating a joint venture with a small-cap Australian miner to develop a new metals processing technology.

View case study →

Startups

Taking a building-products invention from protection to sale

Inotec Global developed Vertical, a flooring installation system using a vertical fold-down process for significantly faster installation. As a two-person startup, the company needed...

View case study →

Startups

Preparing mining-safety technology for international partners

Mikula Technology developed two underground mining safety systems, the Crush-Module and Seismi-Shield, designed to reduce the risk of structural collapse and protect workers. The founders needed...

View case study →

Startups

Turning patented consumer technology into a licensing proposition

A multinational manufacturer held more than 250 patents in industrial automation. Many were used in core products, but a significant portion remained under-used.

View case study →

VC & Private equity

Early-stage medtech valuation using a VC scorecard

An early-stage medtech company was preparing for a capital raise but lacked the revenue history a conventional valuation requires.

View case study →

VC & Private equity

Valuing a clinical-stage biotech asset to support exit planning

A mid-cap ASX-listed biotech had completed Phase I clinical trials and was preparing a global roadshow to explore acquisition or licensing opportunities.

View case study →

Startups

Valuing an early-stage CDMO to inform its funding strategy

A US-domiciled multinational mining company was negotiating a joint venture with a small-cap Australian miner to develop a new metals processing technology.

View case study →

Questions we’re asked

SME & Corporates

SME & Corporates

We can bring together patent attorneys, IP lawyers, valuation and commercial advisers, and insurance specialists under one engagement. The scope can be as focused or broad as needed, from a workshop or targeted review through to detailed analysis and reporting.
Our patent attorneys, IP lawyers, valuers and commercial advisers can assess the same IP from different perspectives. This helps connect the strength and protection of the IP with its commercial importance, risks and value.
More than a royalty database. We consider the rights being licensed, their technical and commercial contribution, available market evidence, the economics of the product or business, and the proposed deal structure.
Yes. We provide independent analysis of royalty rates, value and deal structure to help clients understand the commercial range and assess different options before and during negotiations.
We map IP to the technologies, products, markets and revenue streams the business depends on. This helps identify what should be protected, where the gaps are and which assets justify further investment. We often work through this with management in an IP strategy workshop.
Yes. We identify dormant or underused IP and assess practical options, including licensing, partnerships, carve-outs, internal use and sale. We have helped hundreds of clients unlock value through our integrated services.

Yes. We look across the whole IP position, including registered rights, trade secrets and know-how, ownership and contracts, internal IP processes, third-party exposure and insurance. We then consider the commercial significance of the risks identified so management can decide where action is warranted.

We identify the issues a sophisticated buyer, investor or counterparty is likely to examine: key assets, ownership, strength of protection, commercial strength, and material risks. Addressing them early can prevent them from weakening the deal. Our highly specialised IP analytics, searching aligned with royalty rate assessment, and IP insurance advisory positions our clients for a strong transaction or due diligence process.

We help determine what should be insured, the level of cover required and how the risk should be presented to insurers. We then work with brokers and underwriters on the application and policy structure, so the cover reflects the IP portfolio, its value and the risks the business faces. To learn more or apply, visit Amplisure.

Yes. We identify and rank your highest-value IP assets, helping you focus investment where it will have the greatest impact. Our reports combine insights from patent attorneys, litigators, valuers and insurance specialists to provide a clear view of commercial potential, risk and strategic importance, giving management teams and investors a sound basis for decision-making.

Research institutions & TTOs

We can work directly with the TTO or commercialisation team, with researchers, or alongside existing patent attorneys and legal advisers. Engagements range from a quick assessment or workshop through to detailed valuation, licensing and commercialisation advice.
Yes. Drawing on input from patent attorneys, commercialisation specialists and valuers, we help TTO teams prioritise the opportunities most likely to justify patent filing costs and further investment.
More than a royalty database. We consider a range of factors including the rights being licensed, the strength of the IP, available licensing evidence, the economics of the product or business, and the proposed deal structure. For early-stage research, we also consider development stage, remaining investment and risk, and the respective contributions expected from the licensor and licensee.
Yes. We review proposed licence terms through a legal and commercial lens, helping you understand whether the contributions of each party are recognised. We can also support negotiations by identifying key issues, benchmarking terms and providing independent advice on commercial reasonableness.
Yes. We can value the IP being transferred or licensed to the spinout and help the parties understand its role in the wider transaction. This can inform discussions around licence terms, equity, investment and the respective contributions of the institution, founders and incoming investors.
Yes. We regularly work alongside existing advisers.
Yes. Early-stage opportunities do not always justify a full valuation or royalty opinion. We can start with a focused piece of work, such as invention triage, an initial valuation assessment or licence benchmarking, and build on it if the opportunity progresses. This avoids doing more work than the commercial stage warrants.

Law Firms

We work alongside the legal team, providing advice where it is needed. We can work behind the scenes or directly with the client.
We support law firms across a wide range of IP and commercial matters, including litigation and disputes, damages and royalty assessments, licensing negotiations, M&A transactions, due diligence, ownership disputes, corporate restructures, joint ventures, technology transfers, and cross-border transactions.
Yes. We value patents, trademarks and brands, software, data, trade secrets, know-how, technology platforms and IP-dependent businesses. Valuations can support disputes, transactions, tax, financial reporting, restructuring, licensing and other commercial decisions.
Yes. We work alongside counsel to quantify royalties and damages, providing the valuation and commercial analysis while leaving questions of law to the legal team. Where expert evidence is required, our reports can also be prepared to comply with the relevant court and expert evidence requirements.
Yes. We provide valuation and commercial analysis for disputes involving patents, trademarks and other IP. Depending on the matter, this may include damages or royalty analysis, valuation, market evidence and assessment of the economic significance of the IP.
Yes. We advise on royalty rates, upfront and milestone payments, licence structure and other commercial terms. We can work for licensors or licensees and support counsel before and during negotiations.
Yes. We look at the deal as a whole, including the assets and rights being provided, the contributions and risks of each party, the economics of the arrangement and available market evidence.
Yes. We can assess what IP the target relies on, its commercial importance, how well it is protected and where material gaps or risks may exist. Where required, we can also value the IP or assess how identified issues may affect the transaction.
Yes. We assess IP risk in the context of its potential commercial and financial impact. This can include registered rights, trade secrets and know-how, contractual protections, third-party exposure, internal IP processes and available insurance, depending on the matter.
Yes. Depending on the matter, we can act as independent valuation experts or provide consulting and litigation support to the legal team. The role and scope are agreed at the outset so that applicable independence and expert evidence requirements are appropriately addressed.
Yes. We undertake patent landscape analysis, competitor intelligence, technology mapping, prior-art investigations and freedom-to-operate assessments. Where relevant, this can be combined with valuation and commercial analysis to understand the significance of the findings to the business or matter.
Yes. We help clients identify monetisation opportunities, benchmark royalty arrangements, structure commercial deals, prepare licensing strategies, identify prospective partners and support negotiations.
Yes. We can review valuations, royalty opinions and other commercial analyses prepared by third parties. This can be useful in disputes, transactions and negotiations where counsel needs to understand the strengths and weaknesses of an existing analysis.
Yes. We can provide preliminary valuation and commercial advice to help counsel understand the issues, test positions and assess materiality before deciding whether more detailed analysis is required.

Board, Accounting & other professional services firms

We work alongside the legal team, providing advice where it is needed. We can work behind the scenes or directly with the client.
An intangible asset review identifies and assesses the assets that create competitive advantage and value within a business. By evaluating IP, software, brands, data, know-how and other intangible assets, we help management teams and advisers better understand the factors driving business performance and value creation.
Yes. Many businesses possess valuable intellectual property that has never been formally identified or assessed. We help identify the technology, IP, data, know-how and other intangible assets that underpin products, services and competitive advantage. This can be useful when preparing for a transaction, reviewing strategy, considering risk or simply understanding where value sits within the business.
Yes. The valuation principles overlap, but IP valuation also requires consideration of legal rights, IP strength, and future economic benefit attributable to the asset.
Yes. We value IP and other intangible assets for tax, financial reporting and related purposes, including restructures, transfers to related parties or new entities, transfer pricing arrangements and transactions. We can provide a standalone IP valuation or work alongside your tax, accounting or valuation team.

Venture capital & private equity

We work with investment teams from initial screening and due diligence through to portfolio support and exit. Engagements can range from a focused review of a particular technology or risk to broader diligence, valuation or ongoing support across a portfolio.
Yes. We look at the technology, patents, trade secrets and know-how, competitive alternatives and design-around risk. A large patent portfolio does not necessarily mean strong protection.
Yes. We map the IP to the products, revenue streams and competitive advantages behind the investment thesis. This can expose assumptions about growth, margins or barriers to entry that the IP does not support.
Yes. We assess what the risks could mean commercially and financially and, where appropriate, quantify the impact. That helps determine whether they should affect price, deal terms, post-investment priorities or the decision to proceed.
Yes. We provide concise, independent analysis of IP strength, value and risk for investment papers and IC decisions. We can also undertake deeper work on specific issues where required.
Yes. We identify gaps in protection, unnecessary spend and opportunities to improve the IP position as the business grows. This can include IP strategy, portfolio rationalisation, licensing, risk mitigation and insurance.
Yes. We review the IP as a buyer would, identify issues likely to come up in diligence and help address them before the sale process. Where IP is an important value driver, we can also assess and articulate its contribution to the business.

Startups & emerging companies

Our integrated team provides coordinated advice across IP, legal, valuation and insurance matters, helping startups and emerging companies access specialist expertise without the cost and complexity of engaging multiple advisers. Engagements can be tailored to your stage of growth, from interactive whiteboard sessions and exclusive IP toolkits through to ongoing strategic support. Having commercialised our own IP and supported the licensing, acquisition, protection and commercialisation of hundreds of technologies and products, we provide practical guidance informed by real-world experience.

Many founders have great ideas but are unsure how to protect them, commercialise them or explain them to investors.

We help answer practical questions such as: Should we patent this? Who owns the IP? What is it worth? How do we prepare for investment? How do we make money from it?

Most advisers focus on one piece of the puzzle.

We bring together protection, legal, valuation and commercial expertise, helping founders understand not just how to protect IP, but how to use it to grow value.

Earlier than most founders expect.

Important rights can be lost through investor discussions, product launches, outsourcing arrangements or public disclosure. Getting advice early is usually cheaper than fixing problems later.

Before spending significant money, work out whether the opportunity is commercially attractive and whether you can protect it.

We recommend a free 30 minute initial consultation or a whiteboard session. We love drawing squares and circles, and giving you high-level advice on what to do next and the pitfalls to avoid.

Not always.

The real question is whether a patent will help create value and does it align with your business plan.

In some cases a patent is critical. In others, trade secrets, know-how, software, branding or speed to market may be more important.

Yes. We are not only professional advisers. We have also developed and licensed technology, raised capital for our own start-ups and experienced the founder journey first-hand.

We help founders identify and fix issues before investors find them, including ownership, protection, competitive advantage and valuation.

Investors usually want to know:

  • Who owns the IP?
  • Can competitors copy it?
  • Does it create a genuine advantage?
  • What is it worth?
  • What risks exist?

We help founders prepare clear answers before fundraising begins. Our proprietary tools can also assess the commercial strength of your IP and help support your case for investment. See our Snapshot Score™ case study.

Yes. Our patent attorneys, IP lawyers, valuers and deal advisers turn complex technology into clear, investor-ready materials.

We explain how the technology creates value and why competitors cannot easily copy it.

We use IP audits and risk reviews to identify issues that may reduce value and opportunities to strengthen your business. Where appropriate, tailored IP insurance can also reduce risks that concern investors.

Our article explains how IP insurance support a stronger valuation and capital raise.

Yes. Early-stage valuations are often driven more by technology, market opportunity and growth potential than historical earnings. We help founders understand the factors that investors are likely to consider when assessing value.
We can value patents, software, brands, trademarks, databases, AI systems, trade secrets, know-how and technology platforms.

Yes. Not every business needs a full valuation or large advisory project.

We can start with a focused review of your technology, IP and commercial opportunity, then scale our support as your business grows. Tools such as our Snapshot Score™ provide an affordable first step and can later inform your IP strategy, investor materials or a detailed valuation.

Yes. We help identify potential licensees, buyers and strategic partners, optimise pricing and deal terms, and support negotiations. See how we have helped other clients.

It depends.

The right answer depends on your funding needs, growth plans, appetite for risk and long-term objectives.

We help founders compare the options and determine which approach is likely to create more value.

Yes. A supportable royalty involves more than finding a database benchmark. We consider the IP being licensed, its technical and commercial contribution, available market evidence, the economics of the opportunity and the proposed deal structure.

Yes.

We help founders develop practical plans covering protection, commercialisation, fundraising, growth and exit planning.

Insurance underwriters

As IP valuation experts supported by a multidisciplinary team of patent attorneys, lawyers and valuers, we help insurers, MGAs and underwriters assess complex IP and intangible asset risks. We quantify key risk drivers and provide clear, evidence-based insights to support underwriting, portfolio assessment and policy decisions. Our unique combination of valuation, legal and technical expertise enables us to deliver comprehensive analysis, from patent citation and portfolio assessments through to legal opinions and commercial risk evaluation. Engagements can be tailored to your requirements, from targeted underwriting support and workshops through to ongoing portfolio reviews.

Simple Engagements

Fixed fee

Agreed up front for defined scopes of work. A Snapshot Score™ starts from as little as $2,500.

Fee for service

Hourly or staged for matters that evolve.

White-labelled services

Delivered under your brand when you prefer.

No surprises

Scope and fee confirmed before work starts.